CASE SERIES IN POSTOPERATIVE CARDIAC SURGERY PATIENTS

The International CytoSorb-Registry

The International CytoSorb-Registry Coordinating investigator Overall coordination Prof. Dr. Frank M. Brunkhorst. Jena University Hospital Financial support CytoSorbents Europe GmbH Ways to find truth

Intraoperative application of Cytosorb in cardiac surgery

Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)

CytoSorb Therapy. Indications and Set-up

CytoSorb Therapy Indications and Set-up CytoSorb therapy REGAIN CONTROL The statements in this document do not constitute diagnostic or therapeutic recommendations. It is a best practice collection, based

Proceedings 2nd International Users Meeting, Berlin, Germany October 2nd, 2015

Proceedings 2 nd International Users Meeting, Berlin, Germany October 2 nd, 2015 CYTOSORB - THERAPY REGAIN CONTROL All presentations are available in the CytoSorbents Community Area. Download on cytosorb-therapy.com/eventreview

Systemic Inflammatory Response Syndrome in Heart Surgery: New possibilities for treatment through the use of a cytokine adsorber during ECC?

Systemic Inflammatory Response Syndrome in Heart Surgery: New possibilities for treatment through the use of a cytokine adsorber ABSTRACT The ECC is still the key technology in the performance of cardiac

Thomas Datzmann, Karl Träger

Editorial What about prognostic outcome parameters in patients with acute respiratory distress syndrome (ARDS) treated with veno-venous extracorporeal membrane oxygenation (VV-ECMO)? Thomas Datzmann, Karl

PREVENTION OF RENAL FAILURE

1 st INTERNAT. CYTOSORB USER MEETING 2015 PREVENTION OF RENAL FAILURE DUE TO RHABDOMYOLYSIS xxx A CASE REPORT USING CYTOSORB xi CLAUS-GEORG KRENN / 16. III. 2015 CONFLICT OF INTEREST CGK 2012 - STRATEGIES

CytoSorbentsTM. Proceedings. 4 th International CytoSorb Users` Meeting. March 23 rd 2017, Brussels, Belgium. CytoSorb Therapy REGAIN CONTROL

CytoSorbentsTM Proceedings 4 th International CytoSorb Users` Meeting CytoSorb Therapy REGAIN CONTROL March 23 rd 217, Brussels, Belgium 17 speakers 122 participants 22 countries Table of contents Key

pat hways Medtech innovation briefing Published: 29 November 2016 nice.org.uk/guidance/mib87

pat hways CytoSorb therapy for sepsis Medtech innovation briefing Published: 29 November 2016 nice.org.uk/guidance/mib87 Summary The technology described in this briefing is CytoSorb therapy. It is an

Extracorporeal membrane oxygenation and cytokine adsorption

Review Article Extracorporeal membrane oxygenation and cytokine adsorption Thomas Datzmann, Karl Tra ger Department of Cardiac Anesthesiology, University Hospital Ulm, Ulm, Germany Contributions: (I) Conception

International. CytoSorb. Users Meeting. October 2 nd 2015 Pullman Hotel Schweizer Hof Berlin, Germany

2 nd International CytoSorb Users Meeting October 2 nd 2015 Pullman Hotel Schweizer Hof Berlin, Germany 2nd International CytoSorb Users Meeting Dear CytoSorb user, Just before the start of the 28th Annual

Interessenskonflikt. 1) Cytosorb Register Planung. 2) Studie Seraph Microbind: ExThera Medical. 3) Fan von Arbeitsgruppe PD Dr.

Interessenskonflikt 1) Cytosorb Register Planung 2) Studie Seraph Microbind: ExThera Medical 3) Fan von Arbeitsgruppe PD Dr. David, MHH Cytokinelimination bei Sepsis JanT Kielstein Braunschweig Cytokinelimination

International Users Meeting. Proceedings. 3 rd International CytoSorb Users Meeting Brussels, Belgium, March 14 th, 2016

3 rd International Users Meeting Proceedings 3 rd International CytoSorb Users Meeting Brussels, Belgium, March 14 th, 216 All presentations are available in the CytoSorbents Community Area. CYTOSORB -

Adsorbtion of Cytokines Early in Septic Shock: the ACESS trial

Adsorbtion of Cytokines Early in Septic Shock: the ACESS trial Prof. Zsolt Molnár zsoltmolna@gmail.com Department of Anaesthesia and Intensive Care University of Szeged Hungary Pathophysiology Local insult

CytoSorbentsTM. CytoSorb Therapy: Evidence in septic and vasoplegic shock. 1 st Edition. Studies Case series Selected case reports

CytoSorbentsTM CytoSorb Therapy: Evidence in septic and vasoplegic shock st Edition CytoSorb Therapy REGAIN CONTROL Studies Case series Selected case reports TABLE OF CONTENTS TABLE OF CONTENTS STUDIES

(Peripheral) Temperature and microcirculation

(Peripheral) Temperature and microcirculation Prof. Jan Bakker MD, PhD Chair dept Intensive Care Adults jan.bakker@erasmusmc.nl www.intensivecare.me Intensive Care Med (2005) 31:1316 1326 DOI 10.1007/s00134-005-2790-2

Blood purification in sepsis

Blood purification in sepsis Joannes-Boyau O Dept of anesthesiology and intensive care, University Hospital of Bordeaux, France 1 Types of Blood Purification hemofilters regular pore size (MW < 40,000D)

Septic shock secondary to β-hemolytic streptococcusinduced necrotizing fasciitis treated with a novel cytokine adsorption therapy

Int J Artif Organs 2014; 37 ( 00) : 000-000 DOI: 10.5301/ijao.5000315 SHORT COMMUNICATION Septic shock secondary to β-hemolytic streptococcusinduced necrotizing fasciitis treated with a novel cytokine

Case Report Use of CytoSorb in Traumatic Amputation of the Forearm and Severe Septic Shock

Hindawi Case Reports in Critical Care Volume 2017, Article ID 8747616, 4 pages https://doi.org/10.1155/2017/8747616 Case Report Use of CytoSorb in Traumatic Amputation of the Forearm and Severe Septic

Endothelium as a part of septic Multiple Organ Dysfunction Syndrome (MODS)-is endocan an answer?

Endothelium as a part of septic Multiple Organ Dysfunction Syndrome (MODS)-is endocan an answer? Małgorzata Lipinska-Gediga Department of Anaesthesiology and Intensive Therapy Medical University Wroclaw,

NE refractoriness: From Definition To Treatment... Prof. Alain Combes

NE refractoriness: From Definition To Treatment... Prof. Alain Combes Service de Réanimation ican, Institute of Cardiometabolism and Nutrition Hôpital Pitié-Salpêtrière, AP-HP, Paris Université Pierre

Zacks Small-Cap Research

Zacks Small-Cap Research October 26, 2017 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 CytoSorbents Corporation (CTSO-NASDAQ) CTSO: Additional

3 rd. Edition. Case Series and Case Reports

3 rd Edition Case Series and Case Reports CYTOSORB - THERAPY REGAIN CONTROL MYOGLOBINEMIA SEPSIS LIVER OTHERS CARDIAC SURGERY Table of contents SEPSIS Case series of patients with severe sepsis and septic

Continuous Hemodiafiltration with a Cytokine-Adsorber During Sepsis

Continuous Hemodiafiltration with a Cytokine-Adsorber During Sepsis Department of Plastic and Hand Surgery, Burn Unit, Bergmannstrost Halle, Germany Director: Professor Frank Siemers Khosrow Houschyar,

NON RENAL INDICATIONS OF CRRT ALI AL-AHRASH, MD, PHD AZZAWYIA KIDNEY CENTER

NON RENAL INDICATIONS OF CRRT ALI AL-AHRASH, MD, PHD AZZAWYIA KIDNEY CENTER NON RENAL INDICATIONS OF (CRRT) IN ICU PATIENT SIRS & Sepsis Refractory CHF and Cardiopulmonary bypass Crush syndrome Tumor lysis

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures

ECMO vs. CPB for Intraoperative Support: How do you Choose?

ECMO vs. CPB for Intraoperative Support: How do you Choose? Shaf Keshavjee MD MSc FRCSC FACS Director, Toronto Lung Transplant Program Surgeon-in-Chief, University Health Network James Wallace McCutcheon

When and how to start RRT in critically ill patients? Intensive Care Training Program Radboud University Medical Centre Nijmegen

When and how to start RRT in critically ill patients? Intensive Care Training Program Radboud University Medical Centre Nijmegen Case history (1) 64 Hypertension 2004 AVR 2009 Paravalvular leak - dilated

F12 Sorbent Based and Hybrid Therapies for Extracorporeal Support Continuous Hemodiafiltration with Cytokine-Adsorbing Hemofilters (CAH-CHDF)

F12 Sorbent Based and Hybrid Therapies for Extracorporeal Support Continuous Hemodiafiltration with Cytokine-Adsorbing Hemofilters (CAH-CHDF) Hiroyuki Hirasawa, MD, PhD Professor Emeritus, Department of

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA

Radboud University Nijmegen Medical Centre Why measure cardiac output in critically ill children?

Radboud University Nijmegen Medical Centre Why measure cardiac output in critically ill children? J. Lemson Anesthesiologist/(pediatric)intensivist Case; Girl 2 years, 12 kg, severe meningococcal septic

Shock - from Diagnostic to Therapeutic Implications

Shock - from Diagnostic to Therapeutic Implications Rui Moreno, MD, PhD, Professor UCINC, Hospital de São José Centro Hospitalar de Lisboa Central, E.P.E. LEARNING OBJECTIVES Review the markers of tissue

Case of the Week Compendium

Case of the Week Compendium 2015 Through March 2017 9/2015 Combination ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS Lees N, Rosenberg A, Popov A, Hurtado-Doce

Use of Blood Lactate Measurements in the Critical Care Setting

Use of Blood Lactate Measurements in the Critical Care Setting John G Toffaletti, PhD Director of Blood Gas and Clinical Pediatric Labs Professor of Pathology Duke University Medical Center Chief, VAMC

Hemoadsorption by CytoSorb in septic patients: a case series

Kogelmann et al. Critical Care (2017) 21:74 DOI 10.1186/s13054-017-1662-9 RESEARCH Hemoadsorption by CytoSorb in septic patients: a case series Klaus Kogelmann 1*, Dominik Jarczak 2, Morten Scheller 1

Fluid Management in Critically Ill AKI Patients

Fluid Management in Critically Ill AKI Patients Sang Kyung Jo, MD, PhD Department of Internal Medicine Korea University Medical College KO/MG31/15-0017 Outline Fluid balance in critically ill patients:

LEVELS OF IMMUNOSUPPRESSIVE DRUGS DURING CYTOSORB TREATMENT IN-VITRO STUDY TO COME

LEVELS OF IMMUNOSUPPRESSIVE DRUGS DURING CYTOSORB TREATMENT IN-VITRO STUDY TO COME 2 nd International CytoSorb User s Meeting Zoller et al, 2015 Conclusions: because of the possible adsorption of antibiotics

How to maintain optimal perfusion during Cardiopulmonary By-pass. Herdono Poernomo, MD

How to maintain optimal perfusion during Cardiopulmonary By-pass Herdono Poernomo, MD Cardiopulmonary By-pass Target Physiologic condition as a healthy person Everything is in Normal Limit How to maintain

Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: the EUROMACS-RHF Risk Score Osama I.I. Soliman, MD, PhD, FACC,

Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017

Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017 Pascal Vranckx MD, PhD. Medical director Cardiac Critical Care Services Hartcentrum Hasselt Belgium Disclosure

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Dr. Joseph K Erbe, DO Medical Director Hospitalist Division of Medicine Objectives 1. Review the

International CytoSorb Users Meeting. March 14 th Hotel Marivaux, Brussels

3 rd International CytoSorb Users Meeting March 14 th 2016 - Hotel Marivaux, Brussels 3 rd International CytoSorb Users Meeting Dear CytoSorb user, We are pleased to invite you to our 3rd International

4/4/2014. Of patients diagnosed with sepsis 50% will develop severe sepsis 25% will develop shock. SIRS Sepsis Severe Septic Sepsis Shock.

A summary of pathophysiology, therapeutics, and how the pharmacy TECHNICIAN can help improve OUTCOMES Anthony Nelson 2014 Pharm.D. Candidate Tricia Aggers, Pharm.D. Affiliate Faculty, ISU College of Pharmacy

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE In critically ill patients: too little fluid Low preload,

WHY ADMINISTER CARDIOTONIC AGENTS?

Cardiac Pharmacology: Ideas For Advancing Your Clinical Practice The image cannot be displayed. Your computer may not have enough memory to open the image, or Roberta L. Hines, M.D. Nicholas M. Greene

New Strategies in the Management of Patients with Severe Sepsis

New Strategies in the Management of Patients with Severe Sepsis Michael Zgoda, MD, MBA President, Medical Staff Medical Director, ICU CMC-University, Charlotte, NC Factors of increases in the dx. of severe

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis

Fluorescence immunoassay Point of care test Wide range PCT. whole blood. plasma. serum

Fluorescence immunoassay Point of care test Wide range PCT whole blood serum plasma ichroma PCT Description ichroma PCT along with ichroma Reader is a fluorescence immunoassay for quantitative determination

ECMO & Renal Failure Epidemeology Renal failure & effect on out come

ECMO Induced Renal Issues Transient renal dysfunction Improvement in renal function ECMO & Renal Failure Epidemeology Renal failure & effect on out come With or Without RRT Renal replacement Therapy Utilizes

Fluid balance and clinically relevant outcomes

Fluid balance and clinically relevant outcomes Rui Moreno, MD, PhD, Professor UCINC, Hospital de São José Centro Hospitalar de Lisboa Central, E.P.E. INSULT PRIMARY MODS SIRS SECONDARY MODS OUTCOME RECOVERY

Accepted Manuscript. Extracorporeal Membrane Oxygenation for Septic Shock: Heroic Futility? Francis D. Pagani, MD PhD

Accepted Manuscript Extracorporeal Membrane Oxygenation for Septic Shock: Heroic Futility? Francis D. Pagani, MD PhD PII: S0022-5223(18)31214-5 DOI: 10.1016/j.jtcvs.2018.04.076 Reference: YMTC 12949 To

oxiris A single CRRT set with multiple benefits for managing critically ill patients with AKI Adsorption of inflammatory mediators

oxiris A single CRRT set with multiple benefits for managing critically ill patients with AKI Adsorption of inflammatory mediators Heparin-grafted for reduced thrombogenicity Supports renal function POWERED

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST Cardiogenic Shock Mechanical Support Eulàlia Roig FESC Heart Failure and HT Unit Hospital Sant Pau - UAB Barcelona. Spain No conflics of interest Mechanical Circulatory

AllinaHealthSystem 1

: Definition End-organ hypoperfusion secondary to cardiac failure Venoarterial ECMO: Patient Selection Michael A. Samara, MD FACC Advanced Heart Failure, Cardiac Transplant & Mechanical Circulatory Support

OPCABG for Full Myocardial Revascularisation How we do it

OPCABG for Full Myocardial Revascularisation How we do it 28 th SHA Conferance Dr.Farouk Oueida Head of Cardiac Surgery Dept. SBCC-Dammam KSA The Less Invasive CABG Full Revascularisation Full Sternotomy

Research paper 45. Address: Department of Anaesthesiology, University of Erlangen-Nuremburg, Krankenhausstr. 12, D Erlangan, Germany.

Research paper 45 Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS Michael Meisner, Klaus Tschaikowsky,

The Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya

The Usefulness of Sepsis Biomarkers Dr Vineya Rai Department of Anesthesiology University of Malaya 1 What is Sepsis? Whole Body Inflammatory State + Infection 2 Incidence and Burden of Sepsis in US In

Transfusion & Mortality. Philippe Van der Linden MD, PhD

Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:

ECMO for Refractory Septic Shock Prof. Alain Combes

ECMO for Refractory Septic Shock Prof. Alain Combes Service de Réanimation ican, Institute of Cardiometabolism and Nutrition Hôpital Pitié-Salpêtrière, AP-HP, Paris Université Pierre et Marie Curie, Paris

Sepsis Management Update 2014

Sepsis Management Update 2014 Laura J. Moore, MD, FACS Associate Professor, Department of Surgery The University of Texas Health Science Center, Houston Medical Director, Shock Trauma ICU Texas Trauma

Use of surrogate inflammatory markers in the diagnosis & monitoring of patients with severe sepsis

Thursday 11 th June 2015 Use of surrogate inflammatory markers in the diagnosis & monitoring of patients with severe sepsis Dr Duncan Wyncoll Guy s & St Thomas NHS Trust, London Conflicts of Interest In

Surviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview

Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock An Overview Mechanical Ventilation of Sepsis-Induced ALI/ARDS ARDSnet Mechanical Ventilation Protocol Results: Mortality

Coatings: Are they really effective and how good is the evidence?

Coatings: Are they really effective and how good is the evidence? or is this another example of the Emperor s New Clothes? Richard Tallman, Ph.D. Associate Professor, Emeritus The Ohio State University

Circulatory shock. Types, Etiology, Pathophysiology. Physiology of Circulation: The Vessels. 600,000 miles of vessels containing 5-6 liters of blood

Circulatory shock Types, Etiology, Pathophysiology Blagoi Marinov, MD, PhD Pathophysiology Dept. Physiology of Circulation: The Vessels 600,000 miles of vessels containing 5-6 liters of blood Vessel tone

Steroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye

Steroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye Steroids in ARDS: conclusion Give low-dose steroids if indicated for another problem

Planned, Short-Term RVAD During Durable LVAD Implant: Indications and Management

Planned, Short-Term RVAD During Durable LVAD Implant: Indications and Management Yoshifumi Naka, MD, PhD Columbia University Medical Center New York, NY Disclosure Abbott/St. Jude Med./Thoratec Consultant

Perioperative Management of TAPVC

Perioperative Management of TAPVC Professor Andrew Wolf Rush University Medical Center,Chicago USA Bristol Royal Children s Hospital UK I have no financial disclosures relevant to this presentation TAPVC

Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure

Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure Introduction This pediatric respiratory failure guideline is a supplement to ELSO s General Guidelines for all

Sepsis Pathophysiology

Sepsis Pathophysiology How Kids Differ From Adults Steve Standage Pediatric Critical Care Medicine Seattle Children's Hospital University of Washington School of Medicine Disclosures & Preamble No agenda,

My Special Cytosorb Case. Fabio Silvio TACCONE Dpt of Intensive Care Hôpital Erasme ULB Brussels (BE)

My Special Cytosorb Case Fabio Silvio TACCONE Dpt of Intensive Care Hôpital Erasme ULB Brussels (BE) Conflicts of Interest Clinical Case - 1! 27 yo woman, 45 Kgs (Belgian Vietnam origin)! Blank medical

Minimally invasive aortic valve surgery: new solutions to old problems.

SCDU DI CARDIOCHIRURGIA Università degli Studi di Torino Ospedale S. Giovanni Battista Direttore: Prof. Mauro Rinaldi Minimally invasive aortic valve surgery: new solutions to old problems. Prof. Mauro

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST Multivessel disease and cardiogenic shock: CABG is the optimal revascularization therapy. Contra Prof. Christian JM Vrints Cardiogenic Shock Spiral Acute Myocardial

Irreversible shock can defined as last phase of shock where despite correcting the initial insult leading to shock and restoring circulation there is

R. Siebert Irreversible shock can defined as last phase of shock where despite correcting the initial insult leading to shock and restoring circulation there is a progressive decline in blood pressure

Prevention of Acute Renal Failure Role of vasoactive drugs and diuretic agents

of Acute Renal Failure Role of vasoactive drugs and diuretic agents Armand R.J. Girbes Prof.dr. A.R.J. Girbes Chairman department of Intensive Care VU University Medical Center Netherlands (Failure of)

Low Cardiac Output in the Pediatric Patient

Low Cardiac Output in the Pediatric Patient Jeffrey Burns, M.D., M.P.H. Chief, Division of Critical Care Medicine Children s Hospital Boston Associate Professor of Anesthesia and Pediatrics Harvard Medical

Acute kidney injury after neonatal heart surgery, prevention and management

Acute kidney injury after neonatal heart surgery, prevention and management Mirela Bojan, Simone Gioanni, Philippe Pouard, Department of Anaesthesiology and Intensive Care Necker-Enfants Malades, Paris,

Intra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman

Intra-operative Effects of Cardiac Surgery Influence on Post-operative care Richard A Perryman Intra-operative Effects of Cardiac Surgery Cardiopulmonary Bypass Hypothermia Cannulation events Myocardial

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK Alexandria Rydz BACKGROUND- SEPSIS Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated

Vasopressors in septic shock

Vasopressors in septic shock Prof. Jean-Louis TEBOUL Medical ICU Bicetre hospital University Paris-South France Questions 1- Why do we use vasopressors in septic shock? 2- Which first-line agent? 3- When

INVESTIGATIONAL TREATMENTS FOR SEPSIS AN OVERVIEW

INVESTIGATIONAL TREATMENTS FOR SEPSIS AN OVERVIEW THE GLOBAL BURDEN OF SEPSIS Mortality rate estimated to be 30-50% Rates estimated to be as high as 80% in developing nations One third to one half of all

Systemic inflammatory response syndrome (SIRS) after extracorporeal membrane oxygenation (ECMO): Incidence, risks and survivals.

Thomas Jefferson University Jefferson Digital Commons Department of Surgery Faculty Papers Department of Surgery 9-1-2016 Systemic inflammatory response syndrome (SIRS) after extracorporeal membrane oxygenation

PREVENT COMPLICATIONS IN MAJOR SURGERY

PREVENT COMPLICATIONS IN MAJOR SURGERY Dept of Anesthesia and ICM (Prof. G. Della Rocca) Azienda Ospedaliero-Universitaria University of Udine. Udine, Italy CLINICAL TRIAL OF SURVIVORS CARDIORESPIRATORY

Heart Transplantation in Seniors European View

Heart Transplantation in Seniors European View Hynek RIHA Department of Anesthesiology and Intensive Care Institute for Clinical and Experimental Medicine Prague, Czech Republic 3 rd Int l Symposium: Perioperative

Controversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy

Controversies in Hospital Medicine: Critical Care Vasopressors, Steroids, and Insulin Therapy Douglas Fish, Pharm.D. Professor of Pharmacy, University of Colorado Denver Clinical Specialist in Critical

EXTRACORPOREAL MEMBRANE OXYGENATION

Outcome in Patients Who Require Venoarterial Extracorporeal Membrane Oxygenation Support After Cardiac Surgery Hesham A. Elsharkawy, MD, MSc,* Liang Li, PhD, Wael Ali Sakr Esa, MD, Daniel I. Sessler, MD,

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan

ECMO as a bridge to durable LVAD therapy Jonathan Haft, MD Department of Cardiac Surgery University of Michigan Systolic Heart Failure Prevalence 4.8 million U.S. 287,000 deaths per year $39 billion spent

Management of Cardiogenic shock. Prof. Christian JM Vrints

Management of Cardiogenic shock Prof. Christian JM Vrints none conflicts Management of Cardiogenic Shock Incidence and trends Importance of early revascularization Multivessel disease Left main disease

Innovative ECMO Configurations in Adults

Innovative ECMO Configurations in Adults Practice at a Single Center with Platinum Level ELSO Award for Excellence in Life Support Monika Tukacs, BSN, RN, CCRN Columbia University Irving Medical Center,

Importance of kinetics of procalcitonin in septic patients. János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery

Importance of kinetics of procalcitonin in septic patients János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery Host pathogen interactions the innate and the adaptive

Usefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège

Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators

Maria B. ALBUJA-CRUZ, MD ALBUMIN: OVERRATED. Surgical Grand Rounds

Maria B. ALBUJA-CRUZ, MD ALBUMIN: OVERRATED Surgical Grand Rounds ALBUMIN Most abundant plasma protein 1/3 intravascular 50% of interstitial SKIN Synthesized in hepatocytes Transcapillary escape rate COP

SHOCK Susanna Hilda Hutajulu, MD, PhD

SHOCK Susanna Hilda Hutajulu, MD, PhD Div Hematology and Medical Oncology Department of Internal Medicine Universitas Gadjah Mada Yogyakarta Outline Definition Epidemiology Physiology Classes of Shock

Managing Patients with Sepsis

Managing Patients with Sepsis Diagnosis; Initial Resuscitation; ARRT Initiation Prof. Achim Jörres, M.D. Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum

Update in Critical Care Medicine

Update in Critical Care Medicine Michael A. Gropper, MD, PhD Professor and Executive Vice Chair Department of Anesthesia and Perioperative Care Director, Critical Care Medicine UCSF Disclosure None Update

The Use of Metabolic Resuscitation in Sepsis

The Use of Metabolic Resuscitation in Sepsis Jennifer M. Roth, PharmD, BCPS, BCCCP Critical Care Clinical Specialist - Surgical Trauma ICU Baylor University Medical Center Disclosures No conflicts of interest

Literature on CytoSorb -Therapy and related topics

Literature on CytoSorb -Therapy and related topics Content 1. Clinical Studies 2. Pre-clinical Studies 3. Background & Reviews New Publications: CytoSorb-friend or foe!! Pattnaik SK, Panda B. Indian J

What is the right fluid to use?

What is the right fluid to use? L McIntyre Associate Professor, University of Ottawa Senior Scientist, Ottawa Hospital Research Institute Centre for Transfusion Research CCCF, November 2, 2016 Disclosures

Making vasopressors safer

Making vasopressors safer Requirements for safe vaspressor use In an ideal world 1. Knowledge of what constitutes optimal vasopressor dosing 2. A culture of cautiousness regarding vasopressors What do

Pediatric Septic Shock. Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee

Pediatric Septic Shock Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee Case 4 year old male with a history of gastroschesis repaired

Fluid Treatments in Sepsis: Meta-Analyses

Fluid Treatments in Sepsis: Recent Trials and Meta-Analyses Lauralyn McIntyre MD, FRCP(C), MSc Scientist, Ottawa Hospital Research Institute Assistant Professor, University of Ottawa Department of Epidemiology